GSKMEX:GSKN 73 Days Inventory is 294.33 as of Mar. 2026, which is 36% above its 10-year median of 217.01. GuruFocus rates MEX:GSKN with a GF Score™ of 73/100 and a GF Value™ of MXN818.82 (Fairly Valued). The stock has 1 warning sign investors should review. Among 919 Drug Manufacturers companies, GSK ranks worse than 75.73% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). GSK's Average Total Inventories for the
three
months ended in Mar. 2026 was MXN145,414 Mil. GSK's Cost of Goods Sold for the
three
months ended in Mar. 2026 was MXN45,082 Mil.
Hence, GSK's Days Inventory for the
three
months ended in Mar. 2026 was 294.33.
The historical rank and industry rank for GSK's Days Inventory or its related term are showing as below:
MEX:GSKN'
s Days Inventory Range Over the Past 10 Years
Min: 175.73 Med: 217.01 Max: 274.89
Current: 246.77
During the past 13 years, GSK's highest Days Inventory was 274.89. The lowest was 175.73. And the median was 217.01.
MEX:GSKN's Days Inventory is ranked worse than 75.73% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.44
vs MEX:GSKN: 246.77
GSK's Days Inventory
increased
from Mar. 2025 (274.53) to Mar. 2026 (294.33).
It might indicate that GSK's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
GSK's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GSK's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.79.
GSK (MEX:GSKN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
GSK's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
GSK's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
GSK Days Inventory Related Terms
GSK Days Inventory Historical Data
* Premium members only.
The historical data trend for GSK's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GSKN vs LLY, JNJ, ABBV: Days Inventory Comparison
For the Drug Manufacturers - General subindustry, GSK's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GSK Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GSK's Days Inventory distribution charts can be found below:
* The bar in red indicates where GSK's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GSK (MEX:GSKN) has a Days Inventory of 294.33 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GSK and its competitors. This is 36% above median its historical median of 217.01. Over the past decade, GSK's Days Inventory has ranged from 175.73 to 274.89. According to the industry distribution chart, GSK ranks #696 out of 919 companies in the Drug Manufacturers industry, placing it in the top 75.7%.
Is GSK's Days Inventory too high?
GSK's current Days Inventory of 294.33 is 36% above median its 10-year median of 217.01. Over the past 10 years, this metric has ranged from a low of 175.73 to a high of 274.89. The Drug Manufacturers industry median Days Inventory is 162.44. GSK's value of 294.33 is 81.2% above this industry median. Based on the distribution chart, GSK ranks #696 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, GSK has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GSK's Days Inventory compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, GSK ranks #696 out of 919 companies for Days Inventory. This places GSK in the lower half of its industry. The industry median Days Inventory is 162.44. GSK's value of 294.33 is 81.2% above this benchmark. Historically, GSK's own Days Inventory has ranged from 175.73 to 274.89 over the past decade. While the company's 10-year median is 217.01 vs. the industry median of 162.44, GSK has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.44, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GSK's current Days Inventory of 294.33 is 81.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on GSK and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GSK's current Days Inventory is 294.33, which is 36% above median its own 10-year median of 217.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (MEX:GSKN) is currently considered Fairly Valued. The stock's GF Value™ is MXN818.82, compared to a current price of MXN901.11 — trading 10% above its estimated fair value. The current Days Inventory is 294.33, which is 36% above median its 10-year median of 217.01 and 81.2% above the Drug Manufacturers industry median of 162.44. GSK's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For GSK (MEX:GSKN), the current Days Inventory is 294.33 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GSK (MEX:GSKN) Overvalued in 2026?
Based on GuruFocus' analysis, GSK stock appears to be overvalued.
The current stock price of MXN901.11 is trading 10% above its estimated GF Value™ of MXN818.82.
GuruFocus considers GSK to be Fairly Valued.
Key valuation signals for MEX:GSKN:
Days Inventory: 294.33 (36% above median its 10-year median of 217.01)
GF Value™: MXN818.82 vs. price of MXN901.11 (10% above fair value)
Industry Position: 81.2% above the Drug Manufacturers median (#696 of 919)
No single metric tells the full story. See the MEX:GSKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
73GF Score
Get the complete analysis for MEX:GSKN
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GSKN has been successfully added to your 
